Diagnostic Accuracy of Clinical Tests and Diagnostic Criteria for Piriformis Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorIstanbul University - Cerrahpasa

About this trial

Piriformis syndrome is a clinical condition characterized by buttock pain and/or sciatic-like symptoms, and its diagnosis remains challenging because there is no universally accepted diagnostic standard. This study aims to evaluate the diagnostic accuracy of commonly used diagnostic criteria and clinical tests for piriformis syndrome. Participants with suspected piriformis syndrome will undergo standardized physical examination and assessment of predefined diagnostic criteria. Ultrasound-guided injection of 5 mL of 2% lidocaine into the piriformis muscle will be used as the reference diagnostic procedure. A reduction of 50% or more in pain after injection will be considered confirmation of piriformis syndrome. The diagnostic performance of clinical tests and diagnostic criteria will be analyzed accordingly.

Eligibility criteria

Qualifiers

Adults aged 18 to 75 years

Presentation with gluteal pain

Pain on palpation in the piriformis region

Disqualifiers

History of injection to the lumbar, hip, or gluteal region within the last 3 months,including steroid, hyaluronic acid, or similar injections

History of hip surgery

Presence of active inflammatory rheumatic disease, including rheumatoid arthritis, ankylosing spondylitis, polymyalgia rheumatica, vasculitis, or similar conditions

Active skin or subcutaneous soft tissue infection in the gluteal region

Trial design

Treatments tested in this trial

  • Ultrasound-Guided Piriformis Injection

Treatment groups

75 Participants
are divided into 1 treatment group